Osteosarcoma-specific delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in a patient-derived xenograft model

Status	Active
Effective start/end date	1/01/19 → 30/06/22

Project Details